4.7 Review

Risk Stratification in Primary Biliary Cholangitis

Related references

Note: Only part of the references are listed.
Article Immunology

Using two-step cluster analysis to classify inpatients with primary biliary cholangitis based on autoantibodies: A real-world retrospective study of 537 patients in China

Dan-Tong Zhao et al.

Summary: In this study, autoantibodies in 537 patients with primary biliary cholangitis (PBC) were analyzed to define autoantibody clusters. Five clusters were identified, some of which were associated with cirrhosis and lower survival rates. Additionally, subsets of PBC with benign clinical outcomes were identified. Anti-gp210 was determined to be the strongest predictor for poor outcomes, especially in PBC patients with cirrhosis under real-world conditions.

FRONTIERS IN IMMUNOLOGY (2023)

Review Gastroenterology & Hepatology

Artificial Intelligence in Hepatology- Ready for the Primetime

Rakesh Kalapala et al.

Summary: Artificial Intelligence (AI) is a mathematical process of designing algorithms to support human intelligence. In hepatology, AI has shown promise in improving treatment outcomes by planning appropriate management. Various AI applications in hepatology have been summarized, along with the pitfalls and future implications. AI models and algorithms using different parameters are being studied for diagnosing and managing liver diseases and mass lesions. AI has helped reduce human errors and improve treatment protocols. Further research and validation are needed for future use of AI in hepatology.

JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Optimizing therapy in primary biliary cholangitis: Alkaline phosphatase at six months identifies one-year non-responders and predicts survival

C. Fiorella Murillo Perez et al.

Summary: This study aimed to assess the POISE criteria for treatment response evaluation in patients with primary biliary cholangitis (PBC) and evaluate the utility of alkaline phosphatase (ALP) at six months as a predictor of insufficient response. The results showed that an ALP threshold of 1.9 x ULN at six months accurately identified non-responders.

LIVER INTERNATIONAL (2023)

Review Gastroenterology & Hepatology

Role of autoantibodies in the clinical management of primary biliary cholangitis

Eirini Rigopoulou et al.

Summary: Primary biliary cholangitis (PBC) is a chronic liver disease characterized by immune-mediated destruction of small bile ducts, which can progress to hepatic failure. Early diagnosis and ursodeoxycholic acid treatment have been shown to prevent disease progression in most cases. The presence of disease-specific autoantibodies, including anti-mitochondrial antibodies, anti-sp100 antibodies, and anti-gp210 antibodies, is used for the diagnosis of PBC. These autoantibodies not only aid in the diagnosis of the disease but also have prognostic value. This article summarizes the current knowledge on the detection and clinical significance of PBC-related autoantibodies and discusses the potential prognostic role of novel autoantibodies in PBC patients.

WORLD JOURNAL OF GASTROENTEROLOGY (2023)

Review Gastroenterology & Hepatology

Primary biliary cholangitis: Epidemiology, prognosis, and treatment

Juan Trivella et al.

Summary: Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease characterized by destructive cholangitis and the presence of antimitochondrial antibodies. The prevalence of PBC varies globally and may be higher in males and racial minorities than previously thought. Early recognition and treatment are crucial for PBC outcomes, which can be influenced by provider bias and socioeconomic factors. Ursodeoxycholic acid is the initial treatment choice, with other drugs being considered as add-on therapy. This article provides a comprehensive summary of the epidemiology, prognosis, and treatment of PBC for holistic management.

HEPATOLOGY COMMUNICATIONS (2023)

Article Gastroenterology & Hepatology

New Treatment Paradigms in Primary Biliary Cholangitis

Cynthia Levy et al.

Summary: Primary biliary cholangitis is an autoimmune disease with symptoms including fatigue, itch, abdominal pain, and sicca complex. Treatment focuses on cholestatic consequences.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Machine learning in primary biliary cholangitis: A novel approach for risk stratification

Alessio Gerussi et al.

Summary: Machine learning was used to identify four subgroups of PBC patients with different phenotypes and prognoses. The study emphasized the importance of slight variations in albumin levels within the normal range.

LIVER INTERNATIONAL (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Shear wave elastography and shear wave dispersion imaging in primary biliary cholangitis-a pilot study

Marten Schulz et al.

Summary: This study characterized the severity of liver disease in PBC patients using non-invasive methods including 2D-SWE, SWD, and ATI. The results demonstrate the reliability of 2D-SWE for fibrosis assessment in PBC, and the correlation of SWD with the prognostic marker ALP suggests a potentially valuable role of this new non-invasive method in evaluating liver disease activity in PBC.

QUANTITATIVE IMAGING IN MEDICINE AND SURGERY (2022)

Article Biochemistry & Molecular Biology

Diagnostic and Clinical Value of Specific Autoantibodies against Kelch-like 12 Peptide and Nuclear Envelope Proteins in Patients with Primary Biliary Cholangitis

Alicja Bauer et al.

Summary: The presence of anti-KLHL12 antibodies is highly specific for PBC and may significantly increase the diagnosis of PBC when used in combination with other markers. Anti-nuclear envelope antibodies are more frequent in PBC patients, especially in those diagnosed with later stages of PBC.

BIOMEDICINES (2022)

Review Health Care Sciences & Services

Gender and Autoimmune Liver Diseases: Relevant Aspects in Clinical Practice

Federica Invernizzi et al.

Summary: Autoimmune liver diseases (AILDs) include autoimmune hepatitis, primary biliary cholangitis, and primary sclerosing cholangitis. The etiology of AILD is not well understood but is believed to involve a combination of genetic and environmental factors. AILDs commonly affect young individuals and have a highly variable clinical course. They significantly impact quality of life and can progress to liver decompensation, hepatocellular or cholangiocarcinoma, and end-stage liver disease requiring transplantation. This review highlights the importance of considering sex characteristics and conducting sex-specific analysis in future studies for better understanding and treatment development of AILD.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Article Gastroenterology & Hepatology

Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis

Christophe Corpechot et al.

Summary: In the largest ever study of LSM in patients with PBC, LSM assessed by VCTE improves prediction of survival beyond biochemical response, established prognostic scores, and age categories, independent of time. LSM can reasonably be regarded as a useful prognostic marker and a potential surrogate endpoint in PBC clinical trials.

JOURNAL OF HEPATOLOGY (2022)

Review Immunology

Artificial intelligence for precision medicine in autoimmune liver disease

Alessio Gerussi et al.

Summary: Autoimmune liver diseases (AiLDs) are rare autoimmune conditions of the liver and biliary tree. Artificial intelligence (AI) can support researchers and clinicians in understanding the complexity of AiLDs and developing new treatment options.

FRONTIERS IN IMMUNOLOGY (2022)

Article Gastroenterology & Hepatology

High-Resolution Exposomics and Metabolomics Reveals Specific Associations in Cholestatic Liver Diseases

Douglas I. Walker et al.

Summary: This study utilized a comprehensive exposomics-metabolomics approach to identify potential pathogenic environmental agents and metabolic alterations associated with PSC and PBC. Environmental chemicals, such as pesticides and pollutants, were found to be linked to the diseases, along with alterations in various metabolic pathways shared between the two conditions. The analysis implicated a potential role of the 5-lipoxygenase pathway in the pathogenesis of PSC and PBC.

HEPATOLOGY COMMUNICATIONS (2022)

Article Gastroenterology & Hepatology

Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis

Alessio Gerussi et al.

Summary: The study demonstrated that serum GGT levels are associated with prognosis in patients with PBC, particularly for those requiring liver transplantation or facing liver-related death. A GGT level higher than 3.2-fold the upper limit of normal was identified as a risk marker for interventions in high-risk patients.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis

Yamini Natarajan et al.

Summary: The risk factors for hepatocellular carcinoma (HCC) in patients with primary biliary cholangitis (PBC) are not clear, but cirrhosis and male gender are shown to be significant factors in increasing HCC incidence. Further studies are needed to evaluate additional risk factors in this population and support current recommendations for HCC surveillance in PBC patients with cirrhosis.

DIGESTIVE DISEASES AND SCIENCES (2021)

Article Gastroenterology & Hepatology

Gender and Racial Differences in Hospitalizations for Primary Biliary Cholangitis in the USA

Adeyinka Charles Adejumo et al.

Summary: The hospitalization rate and burden of primary biliary cholangitis (PBC) in the USA have increased disproportionately among females and Hispanics, with higher mortality rates observed among Blacks.

DIGESTIVE DISEASES AND SCIENCES (2021)

Article Gastroenterology & Hepatology

Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcome

Cumali Efe et al.

Summary: This study demonstrates that EHAIDs are frequently diagnosed in patients with PBC, and their presence may influence the clinical presentation of PBC but has no impact on the outcome of PBC.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Liver Stiffness Measured by Either Magnetic Resonance or Transient Elastography Is Associated With Liver Fibrosis and Is an Independent Predictor of Outcomes Among Patients With Primary Biliary Cholangitis

Karim T. Osman et al.

Summary: This study aimed to describe the diagnostic and prognostic performance of TE and MRE in patients with PBC, finding that LS measurements by both TE and MRE outperformed biochemical markers in predicting histologic advanced fibrosis and hepatic decompensation, offering additional prognostic value beyond existing serologic predictive tools.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2021)

Article Gastroenterology & Hepatology

Antibodies to gp210 and understanding risk in patients with primary biliary cholangitis

Debashis Haldar et al.

Summary: In patients with PBC, the presence of anti-gp210 autoantibodies is associated with adverse clinical manifestations, predicts treatment non-response, and independently predicts decreased transplant-free survival.

LIVER INTERNATIONAL (2021)

Article Medicine, General & Internal

Enhanced liver fibrosis score as a surrogate of liver-related complications and mortality in primary biliary cholangitis

Yukihisa Fujinaga et al.

Summary: The study compared serum parameters for liver fibrosis evaluation and clinical outcome prediction in PBC, finding that the ELF score had the highest correlation coefficient and diagnostic performance for liver fibrosis assessment. Patients with an ELF score >= 10.0 had shorter survival and more clinical complications compared to those with an ELF score of <10.0.

MEDICINE (2021)

Article Gastroenterology & Hepatology

Male Sex Is Associated With Higher Rates of Liver-Related Mortality in Primary Biliary Cholangitis and Cirrhosis

Binu John et al.

Summary: In patients with PBC and well-compensated cirrhosis, male sex is associated with a higher risk of both death and liver-related death or transplantation.

HEPATOLOGY (2021)

Review Physiology

The Microbiome in Autoimmune Liver Diseases: Metagenomic and Metabolomic Changes

Yanping Zheng et al.

Summary: Recent studies have highlighted the critical role of microbiota in the pathophysiology of autoimmune liver diseases, showing a significant decrease in gut bacterial diversity in AILDs, with Veillonella commonly enriched in AIH, PBC, and PSC. Furthermore, the oral and bile microbiome appear to be associated with these diseases. Metagenomic functional analysis indicates changes in metabolic pathways in the gut microbiome of these patients, affecting innate and adaptive immunity as well as inflammation.

FRONTIERS IN PHYSIOLOGY (2021)

Article Gastroenterology & Hepatology

Accuracy of Transient Elastography in Assessing Fibrosis at Diagnosis in Naive Patients With Primary Biliary Cholangitis: A Dual Cut-Off Approach

Laura Cristoferi et al.

Summary: In the study of treatment-naive PBC patients, VCTE was found to accurately assess advanced fibrosis (AF) using LSM cutoffs of <= 6.5 and >11.0 kPa. LSM values between these cutoffs were not reliable, requiring liver biopsy for disease staging. BMI and liver biochemistry did not impact LSM measurements.

HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Predictors for incomplete response to ursodeoxycholic acid in primary biliary cholangitis. Data from a national registry of liver disease

Helena Cortez-Pinto et al.

Summary: This study found a considerable proportion of patients with primary biliary cholangitis showed incomplete biochemical response to ursodeoxycholic acid (UDCA) treatment. Patients with cirrhosis, elevated levels of gamma-glutamyl transferase (GGT) and alkaline phosphatase (ALP) at diagnosis were identified as being at higher risk for incomplete response. Early identification of patients at risk of incomplete response could improve treatment care and guide clinical decision-making.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2021)

Article Microbiology

Short-chain fatty acid and fecal microbiota profiles are linked to fibrosis in primary biliary cholangitis

Craig Lammert et al.

Summary: The gut microbiota and metabolome may play a role in the progression of primary biliary cholangitis (PBC). Fecal microbiota and short-chain fatty acids (SCFAs) were assessed in PBC patients according to fibrosis, showing differences in fecal composition between different fibrosis levels. Advanced fibrosis was associated with higher levels of fecal acetate and SCFAs, decreased diversity in microbiota, and a distinct community composition.

FEMS MICROBIOLOGY LETTERS (2021)

Article Gastroenterology & Hepatology

Real-world experience with obeticholic acid in patients with primary biliary cholangitis

Daphne D'Amato et al.

Summary: The study evaluated the effectiveness and safety of Obeticholic acid (OCA) in PBC patients under real-world conditions, finding OCA to be effective in some patients intolerant to ursodeoxycholic acid, but with lower tolerability in cirrhotic patients. It was also observed that patients with overlap of autoimmune hepatitis and PBC responded well to OCA treatment.

JHEP REPORTS (2021)

Review Gastroenterology & Hepatology

Primary biliary cholangitis: pathogenesis and therapeutic opportunities

Aliya F. Gulamhusein et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Novel Anti-Hexokinase 1 Antibodies Are Associated With Poor Prognosis in Patients With Primary Biliary Cholangitis

Anna Reig et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)

Editorial Material Gastroenterology & Hepatology

Role of Antinuclear Antibodies in Primary Biliary Cholangitis

Cynthia Levy et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)

Article Public, Environmental & Occupational Health

Epidemiology and clinical course of primary biliary cholangitis in Eastern Slovakia

Sylvia Drazilova et al.

INTERNATIONAL JOURNAL OF PUBLIC HEALTH (2020)

Article Medical Laboratory Technology

A nomogram based on pretreatment clinical parameters for the prediction of inadequate biochemical response in primary biliary cholangitis

Siyuan Tian et al.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2020)

Article Gastroenterology & Hepatology

Factors Associated With Potential Progressive Course of Primary Biliary Cholangitis Data From Real-world US Database

Zobair M. Younossi et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2019)

Article Gastroenterology & Hepatology

Identification of clinical risk factors for histological progression of primary biliary cholangitis

Yukihisa Fujinaga et al.

HEPATOLOGY RESEARCH (2019)

Review Gastroenterology & Hepatology

Precision medicine in primary biliary cholangitis

Vincenzo Ronca et al.

JOURNAL OF DIGESTIVE DISEASES (2019)

Article Gastroenterology & Hepatology

Fibrosis stage is an independent predictor of outcome in primary biliary cholangitis despite biochemical treatment response

Carla F. Murillo Perez et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)

Article Gastroenterology & Hepatology

Sex differences in clinical presentation and prognosis in patients with primary biliary cholangitis

Mosaab Abdulkarim et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2019)

Article Multidisciplinary Sciences

Incidence, prevalence, and outcome of primary biliary cholangitis in a nationwide Swedish population-based cohort

Hanns-Ulrich Marschall et al.

SCIENTIFIC REPORTS (2019)

Article Gastroenterology & Hepatology

Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades

Maren H. Harms et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2019)

Article Gastroenterology & Hepatology

Acoustic Radiation Force Impulse (ARFI) Elastography in Autoimmune and Cholestatic Liver Diseases

Ruediger S. Goertz et al.

ANNALS OF HEPATOLOGY (2019)

Article Gastroenterology & Hepatology

Effects of Age and Sex of Response to Ursodeoxycholic Arid and Transplant-free Survival in Patients With Primary Biliary Cholangitis

Angela C. Cheung et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

Article Gastroenterology & Hepatology

Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United Kingdom

Vinod S. Hegade et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

Article Gastroenterology & Hepatology

Epidemiology of primary biliary cholangitis in Italy: Evidence from a real-world database

Marco Marzioni et al.

DIGESTIVE AND LIVER DISEASE (2019)

Article Gastroenterology & Hepatology

Prognosis of 732 ursodeoxycholic acid-treated patients with primary biliary cholangitis: A single center follow-up study from China

Sha Chen et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)

Article Gastroenterology & Hepatology

Risk stratification and prognostic modelling in primary biliary cholangitis

Jorn C. Goet et al.

BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2018)

Article Gastroenterology & Hepatology

Influence factors and a predictive scoring model for measuring the biochemical response of primary biliary cholangitis to ursodeoxycholic acid treatment

Jialiang Chen et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)

Article Immunology

Prognostic models in primary biliary cholangitis

Laura Cristoferi et al.

JOURNAL OF AUTOIMMUNITY (2018)

Article Gastroenterology & Hepatology

Liver fibrosis progression predicts survival in patients with primary biliary cirrhosis

Tadashi Namisaki et al.

HEPATOLOGY RESEARCH (2017)

Article Medicine, General & Internal

Geoepidemiology, clinical manifestations and outcome of primary biliary cholangitis in Greece

Nikolaos K. Gatselis et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2017)

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis

Gideon M. Hirschfield et al.

JOURNAL OF HEPATOLOGY (2017)

Article Gastroenterology & Hepatology

Epidemiology and Natural History of Primary Biliary Cholangitis in the Chinese: A Territory-Based Study in Hong Kong between 2000 and 2015

Ka-Shing Cheung et al.

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2017)

Review Medicine, Research & Experimental

Primary Biliary Cholangitis : Its Pathological Characteristics and Immunopathological Mechanisms

Koichi Tsuneyama et al.

JOURNAL OF MEDICAL INVESTIGATION (2017)

Article Gastroenterology & Hepatology

Population-based epidemiology of primary biliary cirrhosis in South Korea

K. -A. Kim et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)

Article Gastroenterology & Hepatology

Making Sense of Autoantibodies in Cholestatic Liver Diseases

Simona Marzorati et al.

CLINICS IN LIVER DISEASE (2016)

Review Gastroenterology & Hepatology

Toward precision medicine in primary biliary cholangitis

Marco Carbone et al.

DIGESTIVE AND LIVER DISEASE (2016)

Article Gastroenterology & Hepatology

Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosis

Gunnar Juliusson et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2016)

Article Multidisciplinary Sciences

Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis

Ana Lleo et al.

SCIENTIFIC REPORTS (2016)

Article Pathology

The Significance of Autoantibody Changes Over Time in Primary Biliary Cirrhosis

Michele M. Tana et al.

AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2015)

Article Gastroenterology & Hepatology

Overlap Syndromes

Olivier Chazouilleres

DIGESTIVE DISEASES (2015)

Article Medicine, General & Internal

Primary biliary cirrhosis

Elizabeth J. Carey et al.

LANCET (2015)

Article Radiology, Nuclear Medicine & Medical Imaging

Comparison of the diagnostic accuracies of magnetic resonance elastography and transient elastography for hepatic fibrosis

Shintaro Ichikawa et al.

MAGNETIC RESONANCE IMAGING (2015)

Article Gastroenterology & Hepatology

Anti-kelch-like 12 and anti-hexokinase 1: novel autoantibodies in primary biliary cirrhosis

Gary L. Norman et al.

LIVER INTERNATIONAL (2015)

Article Gastroenterology & Hepatology

Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis

Lauren N. Bell et al.

LIVER INTERNATIONAL (2015)

Article Gastroenterology & Hepatology

Primary biliary cirrhosis: proposal for a new simple histological scoring system

Dominique Wendum et al.

LIVER INTERNATIONAL (2015)

Article Gastroenterology & Hepatology

Fatigue and pruritus at onset identify a more aggressive subset of primary biliary cirrhosis

Chiara Quarneti et al.

LIVER INTERNATIONAL (2015)

Article Gastroenterology & Hepatology

Autoantibodies in primary biliary cirrhosis: Recent progress in research on the pathogenetic and clinical significance

Satoshi Yamagiwa et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)

Article Gastroenterology & Hepatology

Impact of Primary Biliary Cirrhosis on Perceived Quality of Life: The UK-PBC National Study

George F. Mells et al.

HEPATOLOGY (2013)

Article Gastroenterology & Hepatology

Application and Validation of a New Histologic Staging and Grading System for Primary Biliary Cirrhosis

Kenichi Harada et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2013)

Review Radiology, Nuclear Medicine & Medical Imaging

Magnetic resonance elastography of liver: Technique, analysis, and clinical applications

Sudhakar K. Venkatesh et al.

JOURNAL OF MAGNETIC RESONANCE IMAGING (2013)

Article Gastroenterology & Hepatology

Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis

Rodrigo Liberal et al.

CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2013)

Article Medicine, General & Internal

Primary biliary cirrhosis in Southern Israel: A 20 year follow up study

Jorge-Shmuel Delgado et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2012)

Article Gastroenterology & Hepatology

Varices in Early Histological Stage Primary Biliary Cirrhosis

Ahmad H. Ali et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2011)

Article Gastroenterology & Hepatology

Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome

Christophe Corpechot et al.

JOURNAL OF HEPATOLOGY (2011)

Article Gastroenterology & Hepatology

Overlap syndromes: The International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue

Kirsten Muri Boberg et al.

JOURNAL OF HEPATOLOGY (2011)

Article Gastroenterology & Hepatology

Autoimmune Hepatitis-PBC Overlap Syndrome: A Simplified Scoring System May Assist in the Diagnosis

Matthias Neuhauser et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)

Article Gastroenterology & Hepatology

Baseline Ductopenia and Treatment Response Predict Long-Term Histological Progression in Primary Biliary Cirrhosis

Teru Kumagi et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)

Article Gastroenterology & Hepatology

A Meta-analysis of Transient Elastography for the Detection of Hepatic Fibrosis

Justin Stebbing et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2010)

Review Gastroenterology & Hepatology

Liver Biopsy

Don C. Rockey et al.

HEPATOLOGY (2009)

Review Gastroenterology & Hepatology

EASL Clinical Practice Guidelines: Management of cholestatic liver diseases

Ulrich Beuers et al.

JOURNAL OF HEPATOLOGY (2009)

Article Medicine, Research & Experimental

The value of antinuclear antibodies in primary biliary cirrhosis

Lixia Gao et al.

CLINICAL AND EXPERIMENTAL MEDICINE (2008)

Article Gastroenterology & Hepatology

Antimitochondrial Antibody-Negative Primary Biliary Cirrhosis

Gideon M. Hirschfield et al.

CLINICS IN LIVER DISEASE (2008)

Article Gastroenterology & Hepatology

Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis

Christophe Corpechot et al.

HEPATOLOGY (2008)

Article Gastroenterology & Hepatology

Non-invasive evaluation of liver fibrosis using transient elastography

Laurent Castera et al.

JOURNAL OF HEPATOLOGY (2008)

Review Gastroenterology & Hepatology

Interpreting serological tests in diagnosing autolmmune liver diseases

Pietro Invernizzi et al.

SEMINARS IN LIVER DISEASE (2007)

Article Gastroenterology & Hepatology

Correlation of initial autoantibody profile and clinical outcome in primary biliary cirrhosis

J Wesierska-Gadek et al.

HEPATOLOGY (2006)

Article Gastroenterology & Hepatology

Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome

O Chazouillères et al.

JOURNAL OF HEPATOLOGY (2006)

Article Gastroenterology & Hepatology

Quality of life in patients with primary biliary cirrhosis

RE Poupon et al.

HEPATOLOGY (2004)

Article Acoustics

Transient elastography: A new noninvasive method for assessment of hepatic fibrosis

L Sandrin et al.

ULTRASOUND IN MEDICINE AND BIOLOGY (2003)

Article Acoustics

Acoustic radiation force impulse imaging: In vivo demonstration of clinical feasibility

K Nightingale et al.

ULTRASOUND IN MEDICINE AND BIOLOGY (2002)